|miR-21: an androgen receptor–regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth|
J Ribas, X Ni, M Haffner, EA Wentzel, AH Salmasi, WH Chowdhury, ...
Cancer research 69 (18), 7165-7169, 2009
|Prostate-targeted radiosensitization via aptamer-shRNA chimeras in human tumor xenografts|
X Ni, Y Zhang, J Ribas, WH Chowdhury, M Castanares, Z Zhang, M Laiho, ...
The Journal of clinical investigation 121 (6), 2383-2390, 2011
|Chronic Administration of Valproic Acid Inhibits Prostate Cancer Cell Growth In vitro and In vivo|
Q Xia, J Sung, W Chowdhury, C Chen, N Höti, S Shabbeer, M Carducci, ...
Cancer Research 66 (14), 7237-7244, 2006
|A functional screen identifies miRNAs that inhibit DNA repair and sensitize prostate cancer cells to ionizing radiation|
K Hatano, B Kumar, Y Zhang, JB Coulter, M Hedayati, B Mears, X Ni, ...
Nucleic acids research 43 (8), 4075-4086, 2015
|Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells|
MD Sachs, M Ramamurthy, H Poel, TJ Wickham, M Lamfers, W Gerritsen, ...
Cancer gene therapy 11 (7), 477-486, 2004
|Identification of miR-30b-3p and miR-30d-5p as direct regulators of androgen receptor signaling in prostate cancer by complementary functional microRNA library screening|
B Kumar, S Khaleghzadegan, B Mears, K Hatano, TA Kudrolli, ...
Oncotarget 7 (45), 72593, 2016
|Valproic acid inhibits invasiveness in bladder cancer but not in prostate cancer cells|
CL Chen, J Sung, M Cohen, WH Chowdhury, MD Sachs, Y Li, ...
Journal of Pharmacology and Experimental Therapeutics 319 (2), 533-542, 2006
|Valproic acid, a histone deacetylase inhibitor, is an antagonist for oncolytic adenoviral gene therapy|
N Höti, W Chowdhury, JT Hsieh, MD Sachs, SE Lupold, R Rodriguez
Molecular Therapy 14 (6), 768-778, 2006
|Real-time, Near-Infrared Fluorescence Imaging with an Optimized Dye/Light Source/Camera Combination for Surgical Guidance of Prostate CancerReal-time NIR Image-Guided Surgery …|
BP Neuman, JB Eifler, M Castanares, WH Chowdhury, Y Chen, ...
Clinical Cancer Research 21 (4), 771-780, 2015
|Cyclophosphamide unmasks an antimetastatic effect of local tumor cryoablation|
MY Levy, A Sidana, WH Chowdhury, SB Solomon, CG Drake, ...
Journal of Pharmacology and Experimental Therapeutics 330 (2), 596-601, 2009
|Complications of renal cryoablation: a single center experience|
A Sidana, P Aggarwal, Z Feng, CS Georgiades, BJ Trock, R Rodriguez
The Journal of urology 184 (1), 42-47, 2010
|A real time Metridia luciferase based non-invasive reporter assay of mammalian cell viability and cytotoxicity via the β-actin promoter and enhancer|
SE Lupold, T Johnson, WH Chowdhury, R Rodriguez
PloS one 7 (5), e36535, 2012
|Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo|
MSQ Kortenhorst, S Isharwal, PJ Van Diest, WH Chowdhury, C Marlow, ...
Molecular cancer therapeutics 8 (4), 802-808, 2009
|Mechanism of growth inhibition of prostate cancer xenografts by valproic acid|
A Sidana, M Wang, S Shabbeer, WH Chowdhury, G Netto, SE Lupold, ...
Journal of Biomedicine and Biotechnology 2012, 2012
|Evaluation of prostate-specific membrane antigen as an imaging reporter|
MA Castanares, A Mukherjee, WH Chowdhury, M Liu, Y Chen, RC Mease, ...
Journal of Nuclear Medicine 55 (5), 805-811, 2014
|Characterization of a novel metastatic prostate cancer cell line of LNCaP origin|
MA Castanares, BT Copeland, WH Chowdhury, MM Liu, R Rodriguez, ...
The Prostate 76 (2), 215-225, 2016
|Cryoimmunotherapy in urologic oncology|
A Sidana, WH Chowdhury, EJ Fuchs, R Rodriguez
Urology 75 (5), 1009-1014, 2010
|Adenovirus targeting to prostate-specific membrane antigen through virus-displayed, semirandom peptide library screening|
P Wu, TA Kudrolli, WH Chowdhury, MM Liu, R Rodriguez, SE Lupold
Cancer research 70 (23), 9549-9553, 2010
|Androgen receptor attenuation of Ad5 replication: implications for the development of conditionally replication competent adenoviruses|
N Höti, Y Li, CL Chen, WH Chowdhury, DC Johns, Q Xia, A Kabul, ...
Molecular Therapy 15 (8), 1495-1503, 2007
|Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy|
JL Beebe‐Dimmer, WB Isaacs, KA Zuhlke, C Yee, PC Walsh, SD Isaacs, ...
BJU international 113 (5), 830-835, 2014